Portelli M, Bhaker S, Pang V, Bates D, Johnson S, Mazar A
Clin Transl Allergy. 2023; 13(10):e12293.
PMID: 37876037
PMC: 10542610.
DOI: 10.1002/clt2.12293.
El-Patal M, Khalil M, Shipl W, Barakat I, Youssef E, El Attar S
BMC Oral Health. 2022; 22(1):436.
PMID: 36192745
PMC: 9531525.
DOI: 10.1186/s12903-022-02478-7.
Anchan A, Finlay G, Angel C, Hucklesby J, Graham S
Biosensors (Basel). 2022; 12(8).
PMID: 36005056
PMC: 9405625.
DOI: 10.3390/bios12080660.
Sudhini Y, Wei C, Reiser J
Kidney Dis (Basel). 2022; 8(4):265-274.
PMID: 35949208
PMC: 9251480.
DOI: 10.1159/000524965.
Stefanova V, Crowley V, Weckman A, Kain K
Front Immunol. 2022; 13:931321.
PMID: 35757694
PMC: 9226448.
DOI: 10.3389/fimmu.2022.931321.
Soluble urokinase plasminogen activator receptor is associated with short-term mortality and enhanced reactive oxygen species production in acute-on-chronic liver failure.
Wang Y, Wu F, Chen C, Xu L, Lin W, Huang C
BMC Gastroenterol. 2021; 21(1):429.
PMID: 34789156
PMC: 8597314.
DOI: 10.1186/s12876-021-02006-x.
suPAR, a Circulating Kidney Disease Factor.
Wei C, Spear R, Hahm E, Reiser J
Front Med (Lausanne). 2021; 8:745838.
PMID: 34692736
PMC: 8526732.
DOI: 10.3389/fmed.2021.745838.
Peri-implant Sulcular Fluid Galectin-1, Soluble Urokinase Plasminogen Activator Receptor and IL-1β Levels under Peri-implant Inflammatory Conditions.
Alshiddi I, AlMubarak A, AlQutub M, Alqarawi F, Alshahrani F, Javed F
Oral Health Prev Dent. 2021; 19:503-510.
PMID: 34585876
PMC: 11640701.
DOI: 10.3290/j.ohpd.b2082081.
Periodontal Clinicoradiographic Status and Whole Saliva Soluble Urokinase Plasminogen Activation Receptor and Tumor Necrosis Factor Alpha Levels in Type-2 Diabetic and Non-diabetic Individuals.
Ali D, Qasem S, Baskaradoss J
Oral Health Prev Dent. 2021; 19:481-488.
PMID: 34585873
PMC: 11640750.
DOI: 10.3290/j.ohpd.b2082019.
Exosomes of adult human fibroblasts cultured on 3D silk fibroin nonwovens intensely stimulate neoangiogenesis.
Hu P, Chiarini A, Wu J, Freddi G, Nie K, Armato U
Burns Trauma. 2021; 9:tkab003.
PMID: 34212056
PMC: 8240536.
DOI: 10.1093/burnst/tkab003.
Systemic and topical administration of spermidine accelerates skin wound healing.
Ito D, Ito H, Ideta T, Kanbe A, Ninomiya S, Shimizu M
Cell Commun Signal. 2021; 19(1):36.
PMID: 33752688
PMC: 7986284.
DOI: 10.1186/s12964-021-00717-y.
PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.
Guo Q, Yaron J, Wallen 3rd J, Browder K, Boyd R, Olson T
Front Cardiovasc Med. 2021; 8:633212.
PMID: 33665212
PMC: 7921738.
DOI: 10.3389/fcvm.2021.633212.
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics.
Boylan K, Afiuni-Zadeh S, Geller M, Argenta P, Griffin T, Skubitz A
Clin Proteomics. 2021; 18(1):4.
PMID: 33413078
PMC: 7792339.
DOI: 10.1186/s12014-020-09309-3.
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.
Baart V, Houvast R, de Geus-Oei L, Quax P, Kuppen P, Vahrmeijer A
EJNMMI Res. 2020; 10(1):87.
PMID: 32725278
PMC: 7387399.
DOI: 10.1186/s13550-020-00673-7.
A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome.
Sharma A, Ray S, Mamidipalli R, Kakar A, Chugh P, Jain R
Indian J Crit Care Med. 2020; 24(4):245-251.
PMID: 32565634
PMC: 7297249.
DOI: 10.5005/jp-journals-10071-23385.
Seroprevalence of /CagA Antibodies in Guatemalan Gastric Cancer Patients: Association of Seropositivity with Increased Plasma Levels of Pepsinogens but not Soluble Urokinase Plasminogen Activator Receptor.
Fernandez-Botran R, Wellmann I, Une C, Mendez-Chacon E, Hernandez de Rodas E, Bhandari B
Am J Trop Med Hyg. 2020; 103(1):260-265.
PMID: 32314688
PMC: 7356412.
DOI: 10.4269/ajtmh.19-0934.
Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.
Cooper F, Overmiller A, Loder A, Brennan-Crispi D, McGuinn K, Marous M
J Invest Dermatol. 2018; 138(11):2470-2479.
PMID: 29753032
PMC: 6200597.
DOI: 10.1016/j.jid.2018.04.024.
Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.
Dande R, Peev V, Altintas M, Reiser J
J Diabetes Res. 2017; 2017:3232848.
PMID: 28596971
PMC: 5449757.
DOI: 10.1155/2017/3232848.
Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.
Kronbichler A, Saleem M, Meijers B, Shin J
J Immunol Res. 2016; 2016:2068691.
PMID: 27504461
PMC: 4967695.
DOI: 10.1155/2016/2068691.
Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.
Alfano M, Cinque P, Giusti G, Proietti S, Nebuloni M, Danese S
Sci Rep. 2015; 5:13647.
PMID: 26380915
PMC: 4585377.
DOI: 10.1038/srep13647.